Table 1 |
||||||
|
Increasing expression of IGFBP2 with progression of ovarian serous tumors*. |
||||||
|
Tissue |
IGFBP2 expression (Scores) |
P value |
||||
|
|
||||||
|
3 |
2 |
1 |
0 |
|||
|
|
||||||
|
Normal Ovaries |
◇ |
◇◇◇◇◇ |
0.03# |
|||
|
Borderline Ovarian Tumors |
◇◇◇◇ |
◇ |
||||
|
◇◇ |
◇◇◇◇◇ |
◇◇◇◇◇ |
||||
|
Invasive Ovarian Carcinomas |
◇◇ |
0.03§ |
||||
|
◇◇◇◇◇ |
||||||
|
◇◇◇◇◇ |
◇◇◇◇ |
◇◇◇◇ |
||||
|
◇◇◇◇◇ |
◇◇◇◇◇ |
◇◇◇◇◇ |
◇◇◇◇◇ |
|||
|
|
||||||
|
*Each diamond represents one case (Mann-Whitney U test). #P value between normal ovaries and borderline ovarian tumors §P value between borderline ovarian tumors and invasive ovarian carcinomas |
||||||
|
Lee et al. Molecular Cancer 2005 4:7 doi:10.1186/1476-4598-4-7 |
||||||
